These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 23863455

  • 21. Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine.
    García PC, Paillavil BA, Scioscia N, Dale JB, Legarraga P, Salazar-Echegarai FJ, Bueno SM, Kalergis AM, Wozniak A.
    Microbiol Immunol; 2018 Nov; 62(11):711-719. PubMed ID: 30357922
    [Abstract] [Full Text] [Related]

  • 22. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M, Mortensen R, Calcutt A, Powell J, Batzloff MR, Dietrich J, Good MF.
    J Immunol; 2016 Apr 15; 196(8):3364-74. PubMed ID: 26969753
    [Abstract] [Full Text] [Related]

  • 23. Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization.
    Batzloff MR, Hartas J, Zeng W, Jackson DC, Good MF.
    J Infect Dis; 2006 Aug 01; 194(3):325-30. PubMed ID: 16826480
    [Abstract] [Full Text] [Related]

  • 24. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF.
    J Infect Dis; 2006 Jun 15; 193(12):1666-76. PubMed ID: 16703510
    [Abstract] [Full Text] [Related]

  • 25. Cutting edge issues in rheumatic fever.
    Chang C.
    Clin Rev Allergy Immunol; 2012 Apr 15; 42(2):213-37. PubMed ID: 21597903
    [Abstract] [Full Text] [Related]

  • 26. Prospects for a group A streptococcal vaccine.
    McMillan DJ, Chhatwal GS.
    Curr Opin Mol Ther; 2005 Feb 15; 7(1):11-6. PubMed ID: 15732524
    [Abstract] [Full Text] [Related]

  • 27. Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus.
    Batzloff MR, Yan H, Davies MR, Hartas J, Lowell GH, White G, Burt DS, Leanderson T, Good MF.
    J Infect Dis; 2005 Oct 15; 192(8):1450-5. PubMed ID: 16170764
    [Abstract] [Full Text] [Related]

  • 28. Group A streptococcal vaccines: facts versus fantasy.
    Steer AC, Batzloff MR, Mulholland K, Carapetis JR.
    Curr Opin Infect Dis; 2009 Dec 15; 22(6):544-52. PubMed ID: 19797947
    [Abstract] [Full Text] [Related]

  • 29. Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.
    Chuan YP, Wibowo N, Connors NK, Wu Y, Hughes FK, Batzloff MR, Lua LH, Middelberg AP.
    Biotechnol Bioeng; 2014 Jun 15; 111(6):1062-70. PubMed ID: 24338691
    [Abstract] [Full Text] [Related]

  • 30. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Dale JB, Smeesters PR, Courtney HS, Penfound TA, Hohn CM, Smith JC, Baudry JY.
    Vaccine; 2017 Jan 03; 35(1):19-26. PubMed ID: 27890396
    [Abstract] [Full Text] [Related]

  • 31. Development of Group A streptococcal vaccines: an unmet global health need.
    Sheel M, Moreland NJ, Fraser JD, Carapetis J.
    Expert Rev Vaccines; 2016 Jan 03; 15(2):227-38. PubMed ID: 26559880
    [Abstract] [Full Text] [Related]

  • 32. Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates.
    Zhong W, Skwarczynski M, Toth I.
    Curr Drug Deliv; 2009 Oct 03; 6(5):520-7. PubMed ID: 19863488
    [Abstract] [Full Text] [Related]

  • 33. Status of research and development of vaccines for Streptococcus pyogenes.
    Steer AC, Carapetis JR, Dale JB, Fraser JD, Good MF, Guilherme L, Moreland NJ, Mulholland EK, Schodel F, Smeesters PR.
    Vaccine; 2016 Jun 03; 34(26):2953-2958. PubMed ID: 27032515
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine.
    Finn MB, Penfound TA, Salehi S, Ogega CO, Dold C, Plante O, Dale JB.
    Vaccine; 2024 Sep 17; 42(22):126205. PubMed ID: 39141987
    [Abstract] [Full Text] [Related]

  • 35. Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
    Areschoug T, Carlsson F, Stålhammar-Carlemalm M, Lindahl G.
    Vaccine; 2004 Dec 06; 22 Suppl 1():S9-S14. PubMed ID: 15576204
    [Abstract] [Full Text] [Related]

  • 36. Similar ability of FbaA with M protein to elicit protective immunity against group A streptococcus challenge in mice.
    Ma CQ, Li CH, Wang XR, Zeng RH, Yin XL, Feng HD, Wei L.
    Cell Mol Immunol; 2009 Feb 06; 6(1):73-7. PubMed ID: 19254483
    [Abstract] [Full Text] [Related]

  • 37. Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage.
    Engel ME, Muhamed B, Whitelaw AC, Musvosvi M, Mayosi BM, Dale JB.
    Pediatr Infect Dis J; 2014 Feb 06; 33(2):208-10. PubMed ID: 23934204
    [Abstract] [Full Text] [Related]

  • 38. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N, Olive C, Pruksachatkunakorn C, Pruksakorn S.
    BMC Microbiol; 2006 Aug 09; 6():71. PubMed ID: 16895610
    [Abstract] [Full Text] [Related]

  • 39. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
    McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, Dale JB.
    Clin Infect Dis; 2005 Oct 15; 41(8):1114-22. PubMed ID: 16163629
    [Abstract] [Full Text] [Related]

  • 40. Vaccine strategies to prevent rheumatic fever.
    Brandt ER, Good MF.
    Immunol Res; 1999 Oct 15; 19(1):89-103. PubMed ID: 10374697
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.